Multiply Labs, a robotics company, has developed a new robotic biomanufacturing cluster that achieves “a 74 percent cost reduction” for life-saving cell therapies.
This breakthrough, published in peer-reviewed studies with UCSF, leverages collaborative robot arms from Universal Robots (UR), promising to transform how these complex treatments are produced.
As UR’s first official partner in the cell and gene therapy sector, Multiply Labs’ robotically automated manufacturing processes will significantly expand patient access to therapies currently priced between $300,000 and $2 million per dose. [Read more…] about Multiply Labs reduces costs by 74 percent using Universal Robots